Literature DB >> 15592942

Benzodiazepine receptor-dependent modulation of neutrophil (PMN) free amino- and alpha-keto acid profiles or immune functions.

J Mühling1, J Gonter, K A Nickolaus, R Matejec, I D Welters, M Wolff, A Sablotzki, J Engel, M Krüll, T Menges, M Fuchs, M G Dehne, G Hempelmann.   

Abstract

We have examined the effects of midazolam, Ro 5-4864 (agonist for "peripheral" [p] benzodiazepine receptors [BR]), PK 11195 (antagonist for pBR), flumazenil (antagonist for "central" BR), naloxone (antagonist for opiate receptors) and the combination of midazolam and Ro 5-4864, PK 11195, flumazenil or naloxone on intracellular amino- and alpha-keto acids and the immune function markers superoxide anion (O(2)(-)), hydrogen peroxide (H(2)O(2)) and released myeloperoxidase (MPO) activity in neutrophils (PMN). Only midazolam and Ro 5-4864 led to significant changes in the dynamic PMN free amino- and alpha-keto acid pools. Concerning PMN immune function markers, midazolam and Ro 5-4864 significantly decreased O(2)(-) and H(2)O(2) formation and released MPO. When midazolam and Ro 5-4864 were applied together they appeared to act additively. Pre-incubation with PK 11195 partially neutralized the midazolam effects whereas flumazenil or naloxone showed no effects. We therefore believe that pBR are involved in the signal transmission of anesthetic-induced cellular metabolic changes in PMN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592942     DOI: 10.1007/s00726-004-0136-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  1 in total

1.  Early-stage 11C-Flumazenil PET predicts day-14 selective neuronal loss in a rodent model of transient focal cerebral ischemia.

Authors:  Jessica L Hughes; John S Beech; P Simon Jones; Dechao Wang; David K Menon; Franklin I Aigbirhio; Tim D Fryer; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-22       Impact factor: 6.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.